Pfizer Inc. announced detailed results from two pivotal studies that make up the ELEVATE UC phase 3 registrational programme evaluating etrasimod, a once-daily, oral, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment...
The Serum Institute of India (SII), the world's largest vaccine maker, is considering setting up its first manufacturing plant in Africa as it looks to expand globally after its success in selling COVID-19 shots, its CEO told Reuters on Monday...
Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial...
Results from the DELIVER and DAPA-HF phase III trials demonstrate AstraZeneca’s dapagliflozin’ efficacy in heart failure regardless of ejection fraction. It reached a statistically significant and clinically meaningful reduction in the primary...
Akums Drugs & Pharmaceuticals Ltd acquired the license to manufacture and commercialise Bempedoic acid tablet, the drug which is used for treating high LDL-cholesterol conditions that’s indicative of cardiovascular diseases...
Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the Food and Drug Administration said on Friday...
The development of molecular formulations which become drugs for treating diseases is at the center of the pharmaceutical industry
The 2020s changed the home healthcare industry forever. The Home Medical Equipment (HME) segment of that industry is under more strain than ever. The increase in demand coupled with staffing shortages revealed critical faults in the billing process f
The United States Food and Drug Administration (USFDA) has granted final approval to Glenmark Pharmaceuticals Inc., USA (Glenmark) for Abiraterone Acetate Tablets...
Biocon Biologics, a subsidiary of biopharmaceutical major Biocon and Viatris, an American global healthcare company launched Abevmy (bBevacizumab) , the oncology biosimilar in Canada...